UFF
XLNX

USA Financial Formulas’s Xilinx Inc XLNX Stock Holding History

USA Financial Formulas’s Portfolio XLNX Stock Details XLNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed -$1K – 525
2021
Q4 		$1K Hold
3
– – ﹤0.01% 366
2021
Q3 		$0 Hold
3
– – ﹤0.01% 501
2021
Q2 		$0 Hold
3
– – ﹤0.01% 465
2021
Q1 		$0 Hold
3
– – ﹤0.01% 447
2020
Q4 		$0 Hold
3
– – ﹤0.01% 435
2020
Q3 		$0 Hold
3
– – ﹤0.01% 373
2020
Q2 		$0 Hold
3
– – ﹤0.01% 345
2020
Q1 		$0 Hold
3
– – ﹤0.01% 341
2019
Q4 		$0 Hold
3
– – ﹤0.01% 334
2019
Q3 		$0 Sell
3
-59,924
-100% -$6.56M ﹤0.01% 274
2019
Q2 		$7.6M Buy
59,927
+13,317
+29% +$1.55M 3.81% 8
2019
Q1 		$5.91M Buy
+46,610
New +$5.24M 3.72% 8
2016
Q4 		– Sell
-150,319
Closed -$8.17M – 370
2016
Q3 		$8.17M Buy
+150,319
New +$7.73M 2.1% 9

Other funds holding XLNX

PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return

USA Financial Formulas's XLNX Position: Q1 2022 in Review

USA Financial Formulas sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 3 shares — an estimated $1K sold.

USA Financial Formulas first reported a position in XLNX in Q3 2016 and held it in 13 quarters. The position peaked at $8.17M in Q3 2016. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • USA Financial Formulas reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • USA Financial Formulas sold 3 Xilinx Inc shares in Q1 2022, an estimated $1K.
  • USA Financial Formulas first reported a position in Xilinx Inc in Q3 2016 and held it in 13 quarters.
  • USA Financial Formulas's Xilinx Inc position peaked at $8.17M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.